Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · IEX Real-Time Price · USD
10.40
+0.10 (0.97%)
At close: Apr 26, 2024, 4:00 PM
10.45
+0.05 (0.48%)
After-hours: Apr 26, 2024, 6:05 PM EDT
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $642.25 million as of April 26, 2024. Its market cap has decreased by -60.04% in one year.
Market Cap
642.25M
Enterprise Value
587.95M
1-Year Change
-60.04%
Ranking
Category
Stock Price
$10.40
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $642.25M, a decrease of -27.82%. That is a compound annual growth rate of -10.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 642.30M | 0.97% |
Apr 25, 2024 | 636.10M | -3.46% |
Apr 24, 2024 | 658.90M | -1.76% |
Apr 23, 2024 | 670.70M | -2.16% |
Apr 22, 2024 | 685.50M | 1.18% |
Apr 19, 2024 | 677.50M | -2.66% |
Apr 18, 2024 | 696.00M | -1.14% |
Apr 17, 2024 | 704.00M | -1.12% |
Apr 16, 2024 | 712.00M | -2.96% |
Apr 15, 2024 | 733.70M | - |
Apr 12, 2024 | 733.70M | -5.85% |
Apr 11, 2024 | 779.30M | 1.94% |
Apr 10, 2024 | 764.50M | -0.65% |
Apr 9, 2024 | 769.50M | 1.80% |
Apr 8, 2024 | 755.90M | 1.91% |
Apr 5, 2024 | 741.70M | 1.19% |
Apr 4, 2024 | 733.00M | -3.18% |
Apr 3, 2024 | 757.10M | 2.16% |
Apr 2, 2024 | 741.10M | -3.99% |
Apr 1, 2024 | 771.90M | -4.22% |
Mar 28, 2024 | 805.90M | 5.58% |
Mar 27, 2024 | 763.30M | 7.67% |
Mar 26, 2024 | 708.90M | -3.05% |
Mar 25, 2024 | 731.20M | -2.62% |
Mar 22, 2024 | 750.90M | -3.18% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Varex Imaging | 686.14M |
Mesoblast | 658.81M |
Disc Medicine | 654.54M |
Y-mAbs Therapeutics | 649.65M |
enGene Holdings | 649.17M |
Cogent Biosciences | 624.52M |
Ocular Therapeutix | 624.23M |
ProKidney | 623.08M |